Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity

Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity

US Patent 5200397 · Granted Apr 6, 1993

Estimated economic value: $4,734,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules2024
Stabilized peptide fragments from nucleoredoxin X1 and uses thereof2018
Administration of angiocidin for arresting the growth of a tumor cell2016
Serum markers associated with early and other stages of breast cancer2015
G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker2015
Administration of angiocidin for the treatment of leukemia2014
G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker2013
Method for detecting disease markers2012
Methods and compositions for inhibiting angiogenesis2009
Methods and compositions for inhibiting angiogenesis2007
Diagnosis and treatment of malignant neoplasms2004
Compositions for treating chemotherapy-resistant tumor cells and targeted chemot2002